Randy E. Dobbs Sells 36,261 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD) Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the transaction, the director now owns 107,706 shares in the company, valued at approximately $999,511.68. This represents a 25.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Viemed Healthcare Price Performance

Shares of NASDAQ VMD opened at $9.06 on Friday. The company has a fifty day moving average price of $8.31 and a 200 day moving average price of $7.53. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $10.44. The firm has a market cap of $352.80 million, a PE ratio of 33.56 and a beta of 1.43. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. The firm had revenue of $58.00 million during the quarter. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%.

Institutional Trading of Viemed Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of VMD. Vanguard Group Inc. raised its position in shares of Viemed Healthcare by 53.0% in the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after purchasing an additional 617,009 shares during the period. Kent Lake Capital LLC bought a new stake in shares of Viemed Healthcare during the first quarter worth approximately $5,557,000. Wasatch Advisors LP increased its position in Viemed Healthcare by 19.6% during the 3rd quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock worth $13,552,000 after buying an additional 303,277 shares during the period. Penbrook Management LLC boosted its stake in shares of Viemed Healthcare by 236.0% in the second quarter. Penbrook Management LLC now owns 231,607 shares of the company’s stock valued at $1,517,000 after buying an additional 162,670 shares during the period. Finally, Apis Capital Advisors LLC grew its position in Viemed Healthcare by 193.0% during the second quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock worth $1,535,000 after buying an additional 154,400 shares in the last quarter. Institutional investors own 74.24% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.